Is Medtronic plc (MDT) a Buy, Sell, or Hold?
NYSE : MDT
Medtronic plc
$83.21 USD
$1.2 (1.46%)
- Volume
- 3.43M
- Average Volume
- 10.02M
- Market Capitalization
- $106.51B
- P/E Ratio
- 22.19
- Dividend Yield
- 3.43%
- Price Target
- $91.00
- Year High
- $106.33
- Year Low
- $73.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.76
- Current Ratio
- $2.13
Company Overview
NYSE
Geoffrey Straub Martha
Medical - Devices
Healthcare
MDT
95000
IE
USD
Liquidity Metrics
0.57
2.13
1.62
0.17
0.76
Sales & Valuation
$36.36B
2.93
2.16
19.63
4.23
Profitability
$3.73
$4.8B
13.20%
16.87%
9.85%
5.16%
P/E Metrics
22.19
6.71
6.71
Analyst Price Target & Rating
$91.00
$119.00
$80.00
3/5
51 Analysts
-8.56%
Financial Health Scores
2.78
8/9
$13.13B
$93.03B
$42.96B
$6.85B
Key Metrics (TTM)
$132.52B
3.64
13.64
2.13
9.85%
6.13%
4.50%
5.09%
$57.02
162 days
Company Executives
| Name | Title |
|---|---|
| Alex Gu | Senior VP & President of Greater China Region |
| Thierry Pieton | Executive Vice President & Chief Financial Officer |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer |
| Ingrid Goldberg | Vice President & Head of Investor Relations |
| Brett A. Wall | Executive Officer |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business |
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer |
Poll Results
No votes yet today — be the first to share your view!
About Medtronic plc (NYSE:MDT) Stock
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventi ... ons (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts
2026-07-22 12:06:45
Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with strong success potential. OBIO operates as an innovation and clinical development platform for medical devices, relying on Medtronic and Terumo for commercialization. Medtronic and Terumo have invested a combined $146 million, with OBIO's $220 million valuation reflecting a modest premium to strategic funding and with significant potential upside as catalysts approach.
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
2026-07-21 18:51:05
Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.
2026-07-21 07:00:00
Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery GALWAY, Ireland, July 21, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures.
Andra AP fonden Trims Stock Holdings in Medtronic PLC $MDT
2026-07-21 03:19:20
Andra AP fonden lowered its stake in Medtronic PLC (NYSE: MDT) by 3.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 253,329 shares of the medical technology company's stock after selling 10,400 shares during the quarter. Andra AP fonden's holdings in
Medtronic to announce financial results for its first quarter of fiscal year 2027
2026-07-20 07:00:00
GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A news release containing summary financial information will be issued at 5:45 a.m.
Decker Wealth Management LLC Invests $5.08 Million in Medtronic PLC $MDT
2026-07-20 04:33:04
Decker Wealth Management LLC bought a new position in shares of Medtronic PLC (NYSE: MDT) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 58,614 shares of the medical technology company's stock, valued at approximately $5,079,000. Other
Medtronic PLC $MDT Shares Sold by Allspring Global Investments Holdings LLC
2026-07-18 03:09:48
Allspring Global Investments Holdings LLC cut its stake in Medtronic PLC (NYSE: MDT) by 16.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 885,098 shares of the medical technology company's stock after selling 178,782 shares during the quarter. Allspring Global
2026-07-16 09:00:00
Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹ GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management.
Frequently Asked Questions
-
What is the current Medtronic plc (MDT) stock price?
-
Medtronic plc(NYSE:MDT) stock price is $83.21 in the last trading session. During the trading session, MDT stock reached the peak price of $106.33 while $73.31 was the lowest point it dropped to. The percentage change in MDT stock occurred in the recent session was 1.46% while the dollar amount for the price change in MDT stock was $1.2.
-
MDT's industry and sector of operation?
-
The NYSE listed MDT is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of MDT?
-
Alex Gu | Senior VP & President of Greater China Region
Thierry Pieton | Executive Vice President & Chief Financial Officer
Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer
Ingrid Goldberg | Vice President & Head of Investor Relations
Brett A. Wall | Executive Officer -
How many employees does MDT have?
-
Number of MDT employees currently stands at 95000. MDT operates from Building Two, Parkmore Business Park West, Galway, GA H91 4K49, IE.
-
Link for MDT official website?
-
Official Website of MDT is: https://www.medtronic.com
-
How do I contact MDT?
-
MDT could be contacted at phone #353 1 438 1700 and can also be accessed through its website. MDT operates from Building Two, Parkmore Business Park West, Galway, GA H91 4K49, IE.
-
How many shares of MDT are traded daily?
-
The average number of MDT shares traded daily for last 3 months was 10.02M.
-
What is the market cap of MDT currently?
-
The market value of MDT currently stands at $106.51B with its latest stock price at $83.21